Swiss Pharmaceuticals & Biotech Stable Growth Stocks

Novartis

Market Cap: CHF 200.5b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Dottikon ES Holding

Market Cap: CHF 4.9b

Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia.

Siegfried Holding

Market Cap: CHF 3.2b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Lonza Group

Market Cap: CHF 38.6b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.